Compare General Mills, Inc. (GIS) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Hims and Hers Health Inc — how do they compare? General Mills, Inc. trades at $38.85 (market cap $20.38B), while Hims and Hers Health Inc trades at $29 (market cap $6.99B). The key difference: General Mills, Inc. is far larger — about 2.9× Hims and Hers Health Inc's market cap, and General Mills, Inc. pays a 6.39% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| GIS | HIMS | |
|---|---|---|
Market Cap | $20.38B | $6.99B |
Sector | Consumer Staples | Health |
52-Week High | $51.11 | $62.76 |
52-Week Low | $32.17 | $14.52 |
Enterprise Value | $33.86B | $7.70B |
Dividend Yield | 6.39% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $38.91, up 2.58% today, with a bullish technical signal and mixed earnings history including a recent Q2 2026 beat. The stock shows a low P/E of 9.23 but faces profitability challenges with a negative net income margin of -0.48% for 2026. Recent news highlights cost-saving initiatives and new product launches, while cash flow trends indicate modest net outflows in 2025.
The outlook is cautious; weak sales and margin pressure pose risks, but valuation and dividend yield near 5% offer value. Analysts are predominantly neutral with a consensus price target of $35.36, suggesting limited upside. Key risks include competitive pressures and debt levels, requiring careful monitoring of earnings recovery.
HIMS stock trades at $29.97, down 1.77% amid mixed Q2 2026 results. Revenue growth remains strong at $2.6B for 2026, but profitability concerns persist with a net loss of $142M and negative margins. Technical indicators are neutral with support at $29 and resistance at $31. Recent news highlights multiple securities fraud investigations and FTC scrutiny.
The outlook is cautious. While revenue guidance was raised and analyst consensus targets $33, profitability erosion, margin pressure, and legal overhangs pose significant risks. The stock faces headwinds from declining cash flow and investor skepticism despite growth initiatives in AI and global expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
